Medical Microinstruments S.p.A., a Calci, Pisa, Italy-based maker of a robotic platform for microsurgery, completed a €20M (approx. $24.5M) Series A financing.
The investor syndicate was led by Andera Partners, formerly known as Edmond de Rothschild Investment Partners (EdRIP), with participation from Panakes Partners and Fountain Healthcare, returning seed investor Sambatech, and industry veterans Gus Castello, former Senior Vice President of Product Operations for Intuitive Surgical Inc., and John Engels, founder of AxoGen, Inc. As part of the financing, Andera Partners’ Olivier Litzka, Panakes’ Alessio Beverina, Fountain’s Justin Lynch as well as industry experts Gus Castello, John Engels and Fabrizio Landi, former CEO and founder of Esaote S.p.A. join the board of MMI.
The company intends to use the funds to accelerate the development of its platform, complete product and clinical development, obtain the CE mark and launch in European markets.
Founded in 2015 by Giuseppe M. Prisco, CEO, Carlo Alberto Marcoaldi, Hannah Teichmann, and Massimiliano Simi, MMI has developed a teleoperated robotic platform for suturing in open surgery with wristed microinstruments. The solution enables surgeons to scale motion and eliminate tremor and aims to facilitate existing procedures as well as enable new ones in the domain of microsurgery, from post-oncological and trauma reconstructions to ophthalmology, organ transplantation and pediatric surgery.
The platform is an investigational device and is not yet commercially available.